Professor David Walliker, chief digital and information officer at Manchester University NHS Foundation Trust (MFT) (Credit: MFT)<\/p>\n
Manchester University NHS Foundation Trust (MFT) is launching a platform to give clinicians and approved teams easier access to data to support improvement, research and more informed care for patients.<\/strong><\/p>\n The MDClone<\/a> Ask, Discover, Act, Measure and Share (ADAMS) platform will go live in July 2026. Its synthetic data capability will reduce the need to use real patient data in many scenarios, supporting data safety and privacy.<\/p>\n Across the NHS, large volumes of data are generated, but it can still be difficult to access and use that information quickly enough to support improvement.<\/p>\n The platform will help teams move more quickly from question to insight and identify opportunities to improve quality, productivity and performance.<\/p>\n Professor David Walliker, chief digital and information officer at MFT, said: \u201cThe launch of the ADAMS platform is about giving our clinicians and teams better access to the data they need to improve care for patients.<\/p>\n \u201cBy making it easier for approved users to access and analyse data, it will help us\u00a0identify\u00a0opportunities to improve quality,\u00a0productivity\u00a0and performance more quickly and support faster research and innovation.<\/p>\n \u201cThe platform also strengthens our approach to data safety and privacy. ADAMS sits within MFT\u2019s existing governance framework, keeping data under NHS control and access limited to authorised users.<\/p>\n \u201cIts ability to generate high-fidelity synthetic data will reduce the need to use real patient data in many scenarios,\u00a0providing\u00a0an additional privacy-enhancing capability for improvement,\u00a0research\u00a0and collaboration.\u201d<\/p>\n When the platform goes live next month, MFT\u2019s first area of focus will be kidney disease. ADAMS will help the trust monitor patients\u2019 progress, manage waiting lists and plan its kidney dialysis service across the organisation.<\/p>\n MDClone\u00a0is a healthcare data and AI company that helps organisations use data more effectively for improvement,\u00a0research\u00a0and innovation.<\/p>\n On the launch of ADAMS at MFT, Bruno Lempernesse, chief executive at MDClone, said:\u00a0\u201cMFT is joining other leading hospitals around the world that are using data more effectively to improve care, strengthen research and support safer collaboration.<\/p>\n \u201cWe are proud to partner with an organisation with MFT\u2019s ambition and leadership as it builds long-term capability through the ADAMS platform.\u201d<\/p>\n In March 2026, MFT announced plans to expand the use of AI tools<\/a> across its workforce.<\/p>\n Over the past 18 months, the trust has been working with\u00a0Microsoft<\/a>\u00a0to explore how AI can support staff in their day-to-day work.<\/p>\n